AmTrav vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

AmTrav

EmergingB2B Travel & Expense Management

Corporate Travel Management for Mid-Market

US-focused corporate travel management platform combining technology and personalized service for mid-market companies. Chicago IL.

About

AmTrav is a US-focused corporate travel management company that serves mid-market companies with a combination of modern booking technology and hands-on personal service. Based in Chicago, Illinois, AmTrav positions itself between the large global TMCs that can be impersonal and expensive for mid-market buyers and the self-service technology platforms that lack human support. The company provides an online booking tool with full GDS content, policy management, and reporting, backed by US-based travel consultants who handle complex itineraries, disruptions, and service issues for client travelers.\n\nAmTrav's platform provides air, hotel, and car rental booking with policy compliance and approval workflows, combined with traveler tracking and duty of care capabilities. The company's approach emphasizes responsiveness and relationship-based account management, providing clients with direct access to travel consultants rather than routing all support through offshore call centers as many larger TMCs do. This service model has earned strong satisfaction scores among its customer base of mid-market companies with 500 to 5,000 employees.\n\nAmTrav competes with corporate travel platforms including Navan, TravelBank, and Egencia as well as with mid-market focused TMCs. The company differentiates through its combination of full GDS content access, competitive pricing through its travel industry relationships, and US-based human service. AmTrav has grown steadily by serving the segment of mid-market corporate buyers that value a blend of technology convenience and personal attention for their managed travel programs.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.